Yong DIAO, Chenna ZHENG, Huiyong YANG, Qingyao WANG, Huachun RAO

Association analysis of five SNP variants with gout in the Minnan population in China

Backgrund/aim: There is a very high prevalence of gout in the Minnan population in China. We aimed to explore the genetic characteristics and genetic mechanisms of gout in the Minnan population by studying the association of 5 single nucleotide polymorphisms (SNPs) with gout. Materials and methods: A total of 163 gout patients and 187 normal controls from Minnan were enrolled in this case-control study. SNPs (rs1165205, rs3733591, rs6855911, rs2231142, rs333049) were genotyped by allele-specific polymerase chain reaction (PCR) and analyzed with SPSS 16.0. Results: Significant association with gout was found for rs2231142 (P < 0.001), consistent with our prior studies. An association between rs1333049 and gout was also found (P = 0.03) in the Minnan population. No association of SNPs rs6855911, rs3733591, and rs1165205 was found with gout in the Minnan population. Conclusions: Rs1333049 is associated with gout in the Minnan population, although rs2231142 shows an even stronger association with gout. The C allele of rs1333049 and the A allele of rs2231142 might be crucial risk factors for gou

PDF

___

1. Li YL, Huang HB, Liang B, Chen XY, Cai HY, Li XS. Prevalence survey of hyperuricemia and its association with hypertriglyceridemia and hypertension in elderly people in Quanzhou of Fujian province. Chin J Geriatrics 2013; 7: 1518.
2. Zeng Q, Wang Q, Chen R, Xiao Z, Huang S, Xu J. Primary gout in Shantou: a clinical and epidemiological study. Chin Med J 2003; 116: 6669.
3. Wang Q, Chen R, Du L, Zeng Q. An epidemiological and clinical study of primary gout. Zhonghua Nei Ke 2001; 40: 313315 (in Chinese with abstract in English).
4. Nan H, Qiao Q, Dong Y, Gao W, Tang B, Qian R, Tuomilehto J. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol 2006; 33: 13461350.
5. Dai SM, Han XH, Zhao DB, Shi YQ, Liu Y, Meng JM. Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study. J Rheumatol 2003; 30: 22452251.
6. Miao Z, Li C, Chen Y, Zhao S, Zhao S, Wang Y, Wang Z, Chen X, Xu F, Wang F et al. Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 2008; 35: 18591864.
7. Reimer RJ, Edwards RH. Organic anion transport is the primary function of the SLC17/type I phosphate transporter family. Pflug Arch Eur J Phy 2004; 447: 629635.
8. Li C, Chu N, Wang B, Wang J, Wang J, Luan J, Han L, Meng D, Wang Y, Suo P et al. Polymorphisms in the presumptive promoter region of the SLC2A9 gene are associated with gout in a Chinese male population. PLoS One 2012; 7: e24561.
9. Dehghan A, Köttgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, Boerwinkle E, Levy D, Hofman A, Astor BC et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008; 372: 19531961.
10. Stark K, Reinhard W, Neureuther K, Wiedmann S, Sedlacek K, Baessler A, Fischer M, Weber S, Kaess B, Erdmann J et al. Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large casecontrol study. PLoS One 2008; 3: e1948.
11. McArdle PF, Parsa A, Chang YP, Weir MR, OConnell JR, Mitchell BD, Shuldiner AR. Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in Old Order Amish. Arthritis Rheum 2008; 58: 28742881.
12. Tu HP, Chen CJ, Tovosia S, Ko AM, Lee CH, Ou TT, Lin GT, Chang SJ, Chiang SL, Chiang HC et al. Associations of a nonsynonymous variant in SLC2A9 with gouty arthritis and uric acid levels in Han Chinese subjects and Solomon Islanders. Ann Rheum Dis 2010; 69: 887890.
13. Urano W, Taniguchi A, Anzai N, Inoue E, Sekita C, Endou H, Kamatani N, Yamanaka H. Association between GLUT9 and gout in Japanese men. Ann Rheum Dis 2010; 69: 932933.
14. Hollis-Moffatt JE, Xu X, Dalbeth N, Merriman ME, Topless R, Waddell C, Gow PJ, Harrison AA, Highton J, Jones PB et al. Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian casecontrol sample sets. Arthritis Rheum 2009; 60: 34853492.
15. Hinohara K, Nakajima T, Takahashi M, Hohda S, Sasaoka T, Nakahara K, Chida K, Sawabe M, Arimura T, Sato A et al. Replication of the association between a chromosome 9p21 polymorphism and coronary artery disease in Japanese and Korean populations. J Hum Genet 2008; 53: 357359.
16. Hsu A, Dalbeth N, Gow P, Harrison A, Highton J, Jones PB, Stamp LK, Merriman TR. No evidence for association of Chr 9p21 variant rs1333049 with gout in New Zealand case-control sample sets. Rheumatology 2012; 51: 11291130.
17. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895900.
18. Ugozzoli L, Wallace RB. Allele-specific polymerase chain reaction. Methods 1991; 2: 4248.
19. Villegas R, Xiang YB, Elasy T, Xu WH, Cai H, Cai Q, Linton MF, Fazio S, Zheng W, Shu XO. Purine-rich foods, protein intake, and the prevalence of hyperuricemia: the Shanghai Mens Health Study. Nutr Metab Cardiovas 2012; 22: 409416.
20. Mielants H, Veys EM, de Weerdt A. Gout and its relation to lipid metabolism. II. Correlations between uric acid, lipid, and lipoprotein levels in gout. Ann Rheum Dis 1973; 32: 501505.
21. Li FG, Chu Y, Meng DM, Tong YW. Association of ABCG2 gene C421A polymorphism and susceptibility of primary gout in Han Chinese males. Zhonghua Yi Xue Yi Chuan Xue 2011; 28: 683685 (in Chinese with abstract in English).
22. Dai X, Yuan J, Yao P, Yang B, Yang B, Gui L, Zhang X, Guo H, Wang Y, Chen W et al. Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population. Eur J Epidemiol 2013; 28: 669676.
23. Shishehbor MH, Brennan ML, Aviles RJ, Fu X, Penn MS, Sprecher DL, Hazen SL. Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation 2003; 108: 426431.
24. Woodward OM, Köttgen A, Coresh J, Boerwinkle E, Guggino WB, Köttgen M. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. P Natl Acad Sci USA 2009; 106: 1033810342.
25. Wang B, Meng D, Wang J, Liu S, Zhou S, Miao Z, Han L, Chu N, Zhang K, Ma X et al. Genetic association of polymorphism rs1333049 with gout. Rheumatology 2011; 50: 15591561.
26. Le MT, Shafiu M, Mu W, Johnson RJ. SLC2A9a fructose transporter identified as a novel uric acid transporter. Nephrol Dial Transpl 2008; 23: 27462749.
27. Erridge C, Gracey J, Braund PS, Samani NJ. The 9p21 locus does not affect risk of coronary artery disease through induction of type 1 interferons. J Am Coll Cardiol 2013; 62: 13761381.